ATE92756T1 - Mittel zur behandlung von keratose. - Google Patents

Mittel zur behandlung von keratose.

Info

Publication number
ATE92756T1
ATE92756T1 AT88908350T AT88908350T ATE92756T1 AT E92756 T1 ATE92756 T1 AT E92756T1 AT 88908350 T AT88908350 T AT 88908350T AT 88908350 T AT88908350 T AT 88908350T AT E92756 T1 ATE92756 T1 AT E92756T1
Authority
AT
Austria
Prior art keywords
aqent
active component
injections
shogaol
keratosis
Prior art date
Application number
AT88908350T
Other languages
English (en)
Inventor
Katsuya Uda
Kenji Sakamoto
Mamoru Suekawa
Takeshi Yamamoto
Yuichiro Ohta
Keigo Chisaki
Masaki Aburada
Original Assignee
Tsumura & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP25077687A external-priority patent/JPH0228567B2/ja
Priority claimed from JP63028721A external-priority patent/JPH01207256A/ja
Application filed by Tsumura & Co filed Critical Tsumura & Co
Application granted granted Critical
Publication of ATE92756T1 publication Critical patent/ATE92756T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
AT88908350T 1987-10-06 1988-09-22 Mittel zur behandlung von keratose. ATE92756T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP25077687A JPH0228567B2 (ja) 1987-10-06 1987-10-06 Katsukashochiryozai
JP63028721A JPH01207256A (ja) 1988-02-12 1988-02-12 新規なシス‐（６）‐シヨウガオールおよび該化合物を有効成分とする角化症治療剤
EP88908350A EP0334967B1 (de) 1987-10-06 1988-09-22 Mittel zur behandlung von keratose
PCT/JP1988/000959 WO1989003376A1 (fr) 1987-10-06 1988-09-22 Agent de traitement de la keratose

Publications (1)

Publication Number Publication Date
ATE92756T1 true ATE92756T1 (de) 1993-08-15

Family

ID=26366870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88908350T ATE92756T1 (de) 1987-10-06 1988-09-22 Mittel zur behandlung von keratose.

Country Status (5)

Country Link
EP (1) EP0334967B1 (de)
KR (1) KR920000892B1 (de)
AT (1) ATE92756T1 (de)
DE (1) DE3883208T2 (de)
WO (1) WO1989003376A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2200308T3 (es) * 1997-01-09 2004-03-01 Lmd Utilizacion de shogaoles y de gingeroles para la preparacion de composiciones desodorantes.
FR2758086B1 (fr) * 1997-01-09 1999-02-26 Daniel Jean Shogaols pour l'utilisation comme medicaments, produits cosmetiques et produits dietetiques, procede d'obtention desdits shogaols et extraits vegetaux les contenant
FR2950804B1 (fr) * 2009-10-01 2011-12-23 Oreal Composition, utilisation et procede de conservation
FR2951079B1 (fr) 2009-10-08 2012-04-20 Oreal Composition photoprotectrice a base d'un compose 2-alcoxy-4-alkylcetone phenol ; utilisation dudit compose pour augmenter le facteur de protection solaire
FR2973228B1 (fr) * 2011-04-01 2014-08-01 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
FR2973227B1 (fr) * 2011-04-01 2014-08-08 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
FR2973230B1 (fr) 2011-04-01 2013-11-01 Oreal Utilisation de gingerone ou de ses derives pour diminuer ou retarder les signes du vieillissement de la peau
KR101582188B1 (ko) * 2014-01-20 2016-01-04 한국식품연구원 칸디다 유틸리스를 이용하여 파라돌 함량을 증가시키는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61134338A (ja) * 1984-12-03 1986-06-21 Wako Pure Chem Ind Ltd フエノ−ルケトン化合物の製造法
JPS61137834A (ja) * 1984-12-06 1986-06-25 Wako Pure Chem Ind Ltd 新規フェノールケトン誘導体
JPS61191625A (ja) * 1985-02-19 1986-08-26 Shozo Yanagida 半導体を光触媒とするシス−トランス異性化法
JP2975194B2 (ja) * 1991-11-06 1999-11-10 浜松ホトニクス株式会社 半導体デバイス検査システム
JPH0684231A (ja) * 1992-08-31 1994-03-25 Manatake Fujii 情報伝送によるテレビジョン番組録画予約システム

Also Published As

Publication number Publication date
DE3883208T2 (de) 1993-12-23
EP0334967A4 (en) 1991-11-27
EP0334967A1 (de) 1989-10-04
KR890701526A (ko) 1989-12-20
DE3883208D1 (de) 1993-09-16
KR920000892B1 (ko) 1992-01-30
WO1989003376A1 (fr) 1989-04-20
EP0334967B1 (de) 1993-08-11

Similar Documents

Publication Publication Date Title
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
UA41502C2 (uk) Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
CA2069961A1 (en) Method and compositions for inhibition of disorders associated with oxidative damage
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
HUT63564A (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
KR970061244A (ko) 치매 치료용 약학 조성물
TW362973B (en) Use of 2-anino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a composition having an antidepressant activity
KR930005619A (ko) 위장 질환 치료용 약제
ATE74006T1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
DE3883208D1 (de) Mittel zur behandlung von keratose.
TNSN89039A1 (fr) Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales
KR890004705A (ko) 항바이러스성 제제
KR920702225A (ko) 약학 조성물
JPH06279276A (ja) 免疫不全症候群治療の補助療法剤
JPS5630917A (en) Preventive and remedy for hepatitis
ES2062763T3 (es) Preparacion farmaceutica de 1-octadecil-2-metil-glicero-3-fosfocolina administrable por via intravenosa.
DE3775854D1 (de) Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten.
JPS5793913A (en) Enhancing agent for spermous vital power
DE3783122D1 (de) Verwendung von rekombiniertem menschlichem alpha-interferon zur herstellung eines arzneimittels zur behandlung des aids-virus.
Gjessing et al. Intramuscular injection of procaine penicillin combined with oral administration of ampicillin in the treatment of gonorrhoea
ATE139703T1 (de) Aureobasidin enthaltendes arzneimittel
GB1327465A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase
ATE82016T1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
JPS5498339A (en) Carcinostatic agent
KR900700086A (ko) 뇌기능 개선약

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee